QLD vs. CURE
Compare and contrast key facts about ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE).
QLD and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. QLD is a passively managed fund by ProShares that tracks the performance of the NASDAQ-100 Index (200%). It was launched on Jun 21, 2006. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both QLD and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: QLD or CURE.
Correlation
The correlation between QLD and CURE is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
QLD vs. CURE - Performance Comparison
Key characteristics
QLD:
0.20
CURE:
-0.61
QLD:
0.62
CURE:
-0.58
QLD:
1.09
CURE:
0.92
QLD:
0.23
CURE:
-0.57
QLD:
0.67
CURE:
-1.23
QLD:
14.41%
CURE:
21.15%
QLD:
49.83%
CURE:
44.64%
QLD:
-83.13%
CURE:
-69.19%
QLD:
-22.40%
CURE:
-44.21%
Returns By Period
The year-to-date returns for both stocks are quite close, with QLD having a -13.84% return and CURE slightly lower at -13.86%. Over the past 10 years, QLD has outperformed CURE with an annualized return of 26.25%, while CURE has yielded a comparatively lower 8.38% annualized return.
QLD
-13.84%
34.47%
-15.51%
9.89%
25.21%
26.25%
CURE
-13.86%
-0.41%
-33.16%
-27.11%
8.84%
8.38%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
QLD vs. CURE - Expense Ratio Comparison
QLD has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Risk-Adjusted Performance
QLD vs. CURE — Risk-Adjusted Performance Rank
QLD
CURE
QLD vs. CURE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
QLD vs. CURE - Dividend Comparison
QLD's dividend yield for the trailing twelve months is around 0.26%, less than CURE's 1.35% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
QLD ProShares Ultra QQQ | 0.26% | 0.25% | 0.33% | 0.31% | 0.00% | 0.00% | 0.13% | 0.06% | 0.02% | 0.90% | 0.11% | 0.19% |
CURE Direxion Daily Healthcare Bull 3x Shares | 1.35% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% |
Drawdowns
QLD vs. CURE - Drawdown Comparison
The maximum QLD drawdown since its inception was -83.13%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for QLD and CURE. For additional features, visit the drawdowns tool.
Volatility
QLD vs. CURE - Volatility Comparison
ProShares Ultra QQQ (QLD) has a higher volatility of 26.30% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 24.26%. This indicates that QLD's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.